Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ocean Biomedical Inc. (OCEA:NASDAQ), powered by AI.
Ocean Biomedical Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Ocean Biomedical Inc. on Alpha Lenz.
Ocean Biomedical Inc.'s P/E ratio is -0.0.
“Ocean Biomedical Inc. trades at a P/E of -0.0 (undervalued) with solid ROE of 10.1%.”
Ask for details →Ocean Biomedical Inc. is a life sciences company that focuses on developing and commercializing innovative therapeutics. The company's primary function is to bridge the gap between cutting-edge research and the practical treatment of diseases, particularly those with significant unmet medical needs. Ocean Biomedical collaborates with leading research universities and medical institutions to harness their groundbreaking discoveries for clinical applications. By doing so, they target multiple sectors within the biomedical field, including oncology, infectious diseases, and other critical therapeutic areas. The company plays a significant role in the healthcare market by potentially transforming promising scientific breakthroughs into viable medical treatments, thereby facilitating advancements in patient care and health outcomes globally. Ocean Biomedical Inc.'s work contributes to the dynamic and rapidly evolving landscape of medical science, continually pushing the boundaries of what is possible in the fight against complex diseases.
“Ocean Biomedical Inc. trades at a P/E of -0.0 (undervalued) with solid ROE of 10.1%.”
Ask for details →Ocean Biomedical Inc. (ticker: OCEA) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 7 employees. Market cap is $11,001.
The current price is $0 with a P/E ratio of -0x and P/B of -0x.
ROE is 10.06%.